Literature DB >> 10544912

Two distinct mutations cause severe hemophilia B in two unrelated canine pedigrees.

W Gu1, M Brooks, J Catalfamo, J Ray, K Ray.   

Abstract

The molecular defects causing severe factor IX deficiency were identified in two distinct canine breed-variants. Both defects were associated with an absence of plasma factor IX coagulant activity and antigen. A large deletion mutation was found in 1 breed variant, spanning the entire 5' region of the factor IX gene extending to exon 6. An approximately 5 kb insertion disrupted exon 8 of the second breed-variant. This insertion was associated with alternative splicing between a donor site 5' and acceptor site 3' to the normal exon 8 splice junction, with introduction of a new stop codon. The resultant transcript lacked most of the factor IX catalytic domain and 3' untranslated region. Molecular analyses of canine hemophilia B define an experimental model for study of inhibitor formation and gene therapy strategies, and provide insight into spontaneous mutation mechanisms in the factor IX gene and on the X chromosome of mammalian species.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544912

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

Review 1.  Copy number variation in the domestic dog.

Authors:  Carlos E Alvarez; Joshua M Akey
Journal:  Mamm Genome       Date:  2011-12-04       Impact factor: 2.957

Review 2.  Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B.

Authors:  T C Nichols; R A Raymer; H W G Franck; E P Merricks; D A Bellinger; N DeFriess; P Margaritis; V R Arruda; M A Kay; K A High
Journal:  Haemophilia       Date:  2010-05       Impact factor: 4.287

3.  A deletion causing spontaneous fracture identified from a candidate region of mouse Chromosome 14.

Authors:  Yan Jiao; Xinmin Li; Wesley G Beamer; Jian Yan; Yiai Tong; Daniel Goldowitz; Bruce Roe; Weikuan Gu
Journal:  Mamm Genome       Date:  2005-01       Impact factor: 2.957

Review 4.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

5.  A Line 1 insertion in the Factor IX gene segregates with mild hemophilia B in dogs.

Authors:  Marjory B Brooks; Weikuan Gu; Jennifer L Barnas; Jharna Ray; Kunal Ray
Journal:  Mamm Genome       Date:  2003-11       Impact factor: 2.957

6.  Christmas disease in a Hovawart family resembling human hemophilia B Leyden is caused by a single nucleotide deletion in a highly conserved transcription factor binding site of the F9 gene promoter.

Authors:  Bertram Brenig; Lilith Steingräber; Shuwen Shan; Fangzheng Xu; Marc Hirschfeld; Reiner Andag; Mirjam Spengeler; Elisabeth Dietschi; Reinhard Mischke; Tosso Leeb
Journal:  Haematologica       Date:  2019-03-07       Impact factor: 9.941

7.  A Single Base Insertion in F9 Causing Hemophilia B in a Family of Newfoundland-Parti Standard Poodle Hybrid Dogs.

Authors:  Henrike Kuder; Liubov Sandzhieva-Vuzzo; Alexandra Kehl; Jonathan M Rappaport; Elisabeth Müller; Urs Giger
Journal:  Genes (Basel)       Date:  2021-09-24       Impact factor: 4.096

Review 8.  Genetics of equine bleeding disorders.

Authors:  Anna R Dahlgren; Fern Tablin; Carrie J Finno
Journal:  Equine Vet J       Date:  2020-06-23       Impact factor: 2.888

Review 9.  Understanding hereditary diseases using the dog and human as companion model systems.

Authors:  Kate L Tsai; Leigh Anne Clark; Keith E Murphy
Journal:  Mamm Genome       Date:  2007-07-26       Impact factor: 2.957

Review 10.  Animal models for target diseases in gene therapy--using DNA and siRNA delivery strategies.

Authors:  Ian S Blagbrough; Chiara Zara
Journal:  Pharm Res       Date:  2008-10-08       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.